Supply Chain Brain
Drug shortages remain an ongoing challenge across the healthcare industry, partly due to persistent pandemic-related supply chain issues. In the wake of COVID-19, vulnerability and disconnection across the pharmaceutical supply chain have become more apparent, and leaders in the industry seek improvements through technology. In a recent article from Supply Chain Brain, one executive cited the need for increased visibility at each stage of the supply chain to help predict and manage shortages. Through intelligent inventory management systems, as well as improved communication among manufacturers, distributors, and prescribers, the negative effects of shortages can be mitigated, allowing for better patient experiences and outcomes and more consistency for healthcare facilities.
Share this Post
